TRADE ESTATES Real Estate Investment Company

Transaction in Own Shares • Sep 4, 2025

Announcement Initiation of a share buyback program

TRADE ESTATES REAL ESTATE INVESTMENT COMPANY (the "Company"), following (a) the resolution of its Annual General Meeting of Shareholders held on June 13, 2025, by virtue of which, among other matters, approved the establishment of a share buyback programme pursuant to Article 49 of the Greek Law 4548/2018 (the "Programme") and the granting of the relevant authorizations to the Board of Directors and (b) the resolution of its Board of Directors dated June 25, 2025, hereby announces to the investment community the commencement of the implementation of the Programme as follows:

• The Programme has been agreed upon in accordance with the applicable legislative and regulatory framework, having obtained all necessary regulatory approvals.
• The maximum number of shares that can be acquired under the Program amounts to 12,052,877 shares, representing 10% of the Company's issued share capital, with a minimum purchase price of €1.00 and a maximum purchase price of €5.00 per share. The Programme will be in effect for a period of 24 months, commencing from the date of approval by the General Meeting, that is, until 13 June 2027.

The transactions conducted on the Shares under the Program, as described above, shall be announced to the competent authorities and disclosed to the public in accordance with Article 5 par. (1)(b) of the Regulation (EU) no. 596/2014 of the European Parliament and of the Council of 16 April 2014, the Commission Delegated Regulation 2016/1052 of 8 March 2016 ("MAR")

This announcement is made in accordance with Regulation (EU) no. 596/2014 of the European Parliament and of the Council of 16 April 2014, the Commission Delegated Regulation 2016/1052 of 8 March 2016 and the Resolution No. 25 of the Stock Markets Steering Committee of Athens Exchange.

Maroussi, September 4, 2025

TRADE ESTATES REAL ESTATE INVESTMENT COMPANY Investor Relations and Corporate Announcements Department